Grantham, Mayo, Van Otterloo & Co (GMO)’s Verso Corporation VRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-204,344
Closed -$5.52M 787
2021
Q4
$5.52M Sell
204,344
-325,549
-61% -$7.35M 0.03% 321
2021
Q3
$11M Sell
529,893
-4,400
-0.8% -$84.9K 0.05% 239
2021
Q2
$9.46M Buy
534,293
+92,705
+21% +$1.53M 0.05% 255
2021
Q1
$6.44M Sell
441,588
-44,200
-9% -$581K 0.04% 279
2020
Q4
$5.84M Buy
485,788
+103,122
+27% +$1.02M 0.04% 273
2020
Q3
$3.02M Buy
382,666
+85,000
+29% +$1.03M 0.02% 335
2020
Q2
$3.56M Buy
+297,666
New +$3.9M 0.03% 303
2019
Q4
Sell
-190,100
Closed -$2.35M 787
2019
Q3
$2.35M Sell
190,100
-220,100
-54% -$3.01M 0.02% 399
2019
Q2
$7.81M Buy
410,200
+22,200
+6% +$449K 0.06% 223
2019
Q1
$8.31M Buy
388,000
+338,200
+679% +$7.8M 0.06% 200
2018
Q4
$1.12M Buy
49,800
+34,300
+221% +$927K 0.01% 347
2018
Q3
$522K Buy
+15,500
New +$405K ﹤0.01% 440

Other funds holding VRS

Grantham, Mayo, Van Otterloo & Co (GMO)'s VRS Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Verso Corporation (VRS) in Q1 2022, closing a stake of 204,344 shares — an estimated $5.52M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VRS in Q3 2018 and held it in 12 quarters. The position peaked at $11M in Q3 2021. 20 funds tracked by Wall St. Rank hold VRS as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Verso Corporation position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 204,344 Verso Corporation shares in Q1 2022, an estimated $5.52M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Verso Corporation in Q3 2018 and held it in 12 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Verso Corporation position peaked at $11M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Verso Corporation as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.